A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
Abroad (travel likely)RecruitingPHASE3
Conditions
AIS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Harrison International Peace Hospital, Hengshui, Hebei, China
Daqing Oilfield General Hospital, Daqing, Heilongjiang, China
The First Affiliated Hospital of Nanyang Medicinal College, Nanyang, Henan, China
MeiHekou Central Hospital, Meihekou, Jilin, China
The Affiliated Hospital of Shenyang Medical College, Shenyang, Liaoning, China
Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China
Linyi People's Hospital, Linyi, Shandong, China
Linfen Central Hospital, Linfen, Shanxi, China
Beijing Tiantan Hospital , Capital Medical University, Beijing, China
Contact: Principal Investigator (Zixiao Li)